2016 Press Releases

    Print Page  Close Window
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
11/22/16BioMed Realty Secures New Anchor Tenant For Iconic 500 Kendall Street Building
Shire leases 343,000 square feet as part of 12-year expanded agreement with leading life science real estate companyBOSTON, Nov. 22, 2016 /PRNewswire/ -- Leading life science real estate developer BioMed Realty today announced that Shire Human Genetic Therapies, Inc., a subsidiary of Shire, Plc, will become the next anchor tenant of its iconic 500 Kendall Street building in the heart of Kendall Square. The 12-year lease for 343,000 square feet of office space in the global life science cent... 
Printer Friendly Version
04/14/16BioMed Realty and Bristol-Myers Squibb Sign Lease to Expand Relationship to Entire 256,000-Square-Foot Campus at Woodside Technology Park in Redwood City, Calif.
62,000-Square-Foot Lease Expansion Strengthens Bristol-Myers Squibb's Presence in the Bay Area SAN FRANCISCO, April 14, 2016 /PRNewswire/ -- BioMed Realty announced today that Bristol-Myers Squibb signed a new lease at the Woodside Technology Park life science campus in Redwood City, Calif.The 62,000-square-foot expansion adds a third building to Bristol-Myers Squibb's existing 194,000 square feet at the company's Bay Area hub for discovering pioneering cancer therapies in th... 
Printer Friendly Version
04/05/16Biomed Realty Announces Illumina, Inc., as Sole Tenant for San Diego i3 Campus
Genomics Leader Will Lease the Entire 316,000 Square Foot Campus for Office Expansion   San Diego, CA – April 5, 2016 – BioMed Realty today announced that Illumina, Inc. (NASDAQ: ILMN), a world leader in genomics focused on improving human health by unlocking the power of the genome, has signed a 10 year lease at BioMed Realty's i3 campus, a 316,000 square foot development currently under construction in the University Towne Centre (UTC) life science market of San Diego. i3 wil... 
Printer Friendly Version
01/27/16Blackstone Completes Acquisition Of BioMed Realty Trust
SAN DIEGO, Jan. 27, 2016 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) (the "Company") announced today the completion of its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P. The total transaction value is approximately $8 billion. Pursuant to the transaction, holders of shares of common stock of BioMed Realty will be entitled to receive $23.8239 in cash, without interest, in exchange for each share of common stock they own, which represents a... 
Printer Friendly Version
01/25/16BioMed Realty Trust Announcement Relating To Completion Of Acquisition By Blackstone
SAN DIEGO, Jan. 25, 2016 /PRNewswire/ -- Due to the storm-related closure of government offices in the State of Maryland, BioMed Realty Trust, Inc. (NYSE: BMR) announced that it expects that the closing of the acquisition of BioMed Realty by affiliates of Blackstone Real Estate Partners VIII ("Blackstone") will be delayed until later this week, subject to the satisfaction or waiver of all closing conditions related to the transaction, at which time trading of the Company's shares on the New York... 
Printer Friendly Version
01/22/16BioMed Realty Trust Announces Tax Treatment Of 2015 Distributions
SAN DIEGO, Jan. 22, 2016 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced the tax treatment of its 2015 distributions.  The following table summarizes, for income tax purposes, the nature of the cash distributions paid by the company to stockholders during the year ended December 31, 2015 and the appropriate 1099DIV box number: Security Description: Common Stock CUSIP: 09063H107 Ticker Symbol: BMR Rec... 
Printer Friendly Version
01/21/16BioMed Realty Trust Stockholders Approve Acquisition By Blackstone
SAN DIEGO, Calif., Jan. 21, 2016 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced that its common stockholders approved the acquisition of BioMed Realty by affiliates of Blackstone Real Estate Partners VIII ("Blackstone") at its special meeting of stockholders held earlier today. Subject to the satisfaction or waiver of all closing conditions related to the transaction, BioMed Realty expects the transaction to close on January 26, 2016, at which time trading of the Company's share... 
Printer Friendly Version